E.G Goes In on the F.D.A approves Medicine Marijuana also Talks about does size matter.............
This approval is the culmination of GW’s many years of partnership with patients, their families,...
Renegade Talk Radio · Renegade Talk Radio
June 26, 201823m 5sExplicit
Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This approval is the culmination of GW’s many years of partnership with patients, their families, and physicians in the epilepsy community to develop a much needed, novel medicine,” GW CEO Justin Gover said in a statement. “These patients deserve and will soon have access to a cannabinoid medicine that has been thoroughly studied in clinical trials, manufactured to assure quality and consistency, and available by prescription under a physician’s care.”
A company representative said the list price for the medication had not been set yet.
Patients with Lennox-Gastaut and Dravet syndromes, which typically emerge in the first few years of life, can suffer from debilitating and recurrent seizures, sometimes dozens a day. One in five patients is estimated to die before they are 20 years old.
There are six other drugs approved to treat seizures associated with Lennox-Gastaut, but none approved for Dravet.
A company representative said the list price for the medication had not been set yet.
Patients with Lennox-Gastaut and Dravet syndromes, which typically emerge in the first few years of life, can suffer from debilitating and recurrent seizures, sometimes dozens a day. One in five patients is estimated to die before they are 20 years old.
There are six other drugs approved to treat seizures associated with Lennox-Gastaut, but none approved for Dravet.
Topics
radionews&politicsgloverfdasexmariajunamusicdonaldtalktalkradio